The independent source for health policy research, polling, and news.
3,841 - 3,860 of 15,457 Results
The state says it will look at the levels of disease-fighting antibodies among nursing home residents vaccinated against covid, which could help indicate whether they need a booster shot.
The summer that promised to let Americans resume a relatively normal life is turning into another summer of anxiety and face masks, as the delta variant drives covid caseloads up in all 50 states. Meanwhile, the Americans with Disabilities Act turns 35, and the Missouri Supreme Court orders the state to expand Medicaid after all. Mary Ellen McIntire of CQ Roll Call, Anna Edney of Bloomberg News and Rachana Pradhan of KHN join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews KHN’s Samantha Young, who reported and wrote the latest KHN-NPR “Bill of the Month” episode about an Olympic-level athlete with an Olympic-size medical bill.
Pharmaceutical companies routinely cover the cost of patient copays for expensive drugs under private insurance. A federal judge could make the practice legal for millions on Medicare as well.
Each year, people in pain travel to Montana and pay to sit amid radon gas, which is pitched as therapy for a long list of health issues. While low-dose radiation therapy is getting another look amid the pandemic, experts say that treatment is different than sitting in a tunnel of radioactive gas.
A bicyclist from California competed in a Pennsylvania race that could have landed him in this month’s Tokyo Olympics. Instead, a crash on the velodrome track landed him in two hospitals where his out-of-state, out-of-network surgeries garnered huge bills.
Scientists are trying to piece together why the delta variant so readily infects unvaccinated Americans, spewing 1,000 times more virus particles.
Brexanolone is a promising new treatment for postpartum depression. But one insurer's requirement that women try four other drugs and electroconvulsive therapy before the infusion means it is out-of-reach for millions of women.
The most recent covid relief law offered federal funding to pay insurance premiums for workers who lost their jobs and opted to keep their workplace insurance through COBRA. But the window to take advantage of the subsidized coverage is closing: Many workers would need to enroll in the program by July 31.
U.S. Rep. Sharice Davids (D-Kansas) introduced a bill to do away with a health insurance rule that dictates which parent’s plan becomes a new baby’s primary insurer. This could save some parents from unexpected, sometimes massive medical bills. Davids took up the issue after a KHN/NPR Bill of the Month story on one family’s unexpected $207,455 NICU bill.
In a suburb of Denver, a doctor runs a clinic that finds creative solutions to treat a large refugee and immigrant population, sometimes to the dismay of the medical establishment.
At a pop-up vaccine clinic in a McDonald’s parking lot in the city of San Bernardino, fewer than two dozen people agreed to get a shot, offering a snapshot of the faltering vaccination effort.
Missouri is the last state to create a monitoring program to help spot the misuse of prescription drugs. But some public health experts warn that the nation’s programs are forcing people addicted to opioids to seek deadlier street options.
While covid is generally mild in children, doctors report a growing number of long-haul covid symptoms and MIS-C cases, particularly among Black and Latino children.
Patients seem to like remote visits, and health care providers now depend on them. But outages, freezing and other glitches cost time and money, and compromise quality of care.
KHN and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here’s a collection of their appearances.
The landmark federal health law required most commercial health plans to cover a comprehensive list of birth control methods approved by the Food and Drug Administration free of charge to female patients. But health plans don’t have to cover every option, and newer methods are not included in the federal list of covered services.
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
The makers of Aduhelm, a drug approved last month despite concerns raised by experts about its effectiveness, have launched a website and ads designed to urge people who are worried about their memory to ask doctors about testing. But some health advocates say it is misleading because some memory loss with aging is normal.
A year and a half after Sutter Health agreed to a tentative settlement in a closely watched antitrust case, the San Francisco judge presiding over the case indicated she would sign off on the terms, pending agreement on another contentious issue: attorney fees.
With covid cases on the upswing again around the country, partisan division remains over how to address the pandemic. Meanwhile, the Biden administration proposes bigger penalties for hospitals that fail to make their prices public as required. Stephanie Armour of The Wall Street Journal, Alice Miranda Ollstein of Politico and Tami Luhby of CNN join KHN’s Julie Rovner to discuss these issues and more. Also, for “extra credit,” the panelists suggest their favorite stories of the week they think you should read, too.
© 2026 KFF